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Trans-synaptic organizing cues must be passed
between synaptic partners for synapses to properly
form. Much of our understanding of this process
stems from studies at the neuromuscular junction,
where target-derived growth factors, extracellular
matrix (ECM) molecules, and matricryptins (proteo-
lytically released fragments of ECM molecules) are
all essential for the formation and maintenance of
motor nerve terminals. While growth factors and
ECM molecules also contribute to the formation of
brain synapses, it remains unclear whether synaptic
roles exist for matricryptins in the mammalian brain.
We report that collagen XVIII and its matricryptin
endostatin are generated by cerebellar Purkinje cells
and are necessary for the organization of climbing
fiber terminals in these neurons. Moreover, endosta-
tin is sufficient to induce climbing fiber terminal for-
mation in vitro by binding and signaling through
a3b1 integrins. Taken together, these studies reveal
roles for both matricryptins and integrins in the orga-
nization of brain synapses.
INTRODUCTION
Synapses, which allow the transfer of information between cells
in the nervous system, begin to form when growing axons
contact appropriate target cells. After initial contact, molecular
signals are passed between synaptic partners to transform the
axon and postsynaptic target into a synapse. First insight into
the molecular signals that mediate this process (termed synaptic
differentiation) came from studies at the neuromuscular junction
(NMJ), where trans-synaptic cues, in the form of growth factors,
morphogens, and extracellular matrix (ECM) molecules, induce
pre- and postsynaptic differentiation (Fox and Umemori, 2006).
Recent studies have further demonstrated that proteolyticallyreleased fragments of ECM molecules also contribute to NMJ
formation (Fox et al., 2007). Specifically, controlled proteolysis
of several collagen molecules generates soluble peptides,
termed matricryptins, that exhibit unique bioactivities compared
to the full-length molecule from which they are derived (Ricard-
Blum and Ballut, 2011). At the NMJ, collagen IV-derived matri-
cryptins direct the assembly and maintenance of motor nerve
terminals (Fox et al., 2007).
Despite anatomical differences, the formation of central
synapses is remarkably similar to that of the NMJ in that trans-
synaptic cues direct synaptic differentiation (Fox and Umemori,
2006). In fact, many of the same families of molecules that direct
NMJ formation contribute to synapse formation in the brain.
Examples include Wnts, FGFs, agrin, and laminins (Terauchi
et al., 2010; Ksiazek et al., 2007; Egles et al., 2007). It remains
unclear, however, whether roles for matricryptins exist at central
synapses. Here, we screened for matricryptin-releasing colla-
gens in brain and discovered that cerebellar Purkinje cells ex-
press collagen XVIII. Using in vivo and in vitro approaches, we
showthatcollagenXVIII is necessary for theorganizationof climb-
ing fiber (CF) terminals, and endostatin—the matricryptin re-
leased from this collagen—is sufficient to induce their formation.
RESULTS AND DISCUSSION
Matricryptin Expression in Cerebellum
To assess whether matricryptins are present in the mammalian
brain, we screened for collagen gene expression in mouse brain.
One collagen gene, col18a1 (which encodes collagen XVIII), was
exclusively enriched in cerebellum (Figure 1A). Outside of
the nervous system, three col18a1 isoforms are expressed in
tissue-specific manners (Muragaki et al., 1995); however, we
found that all were expressed in cerebellum (Figures S1A and
S1B). Using primers and riboprobes that detect all col18a1 iso-
forms, we found that expression coincides with synaptogenesis
(Figure 1B) and is restricted to a single class of neurons—
Purkinje cells (Figures 1C, 1D, and S1C).
Collagen XVIII is a heparan sulfate proteoglycan and harbors
a C-terminal matricryptin termed endostatin. Outside of theCell Reports 2, 223–230, August 30, 2012 ª2012 The Authors 223
Figure 1. Expression of Collagen XVIII/Endostatin in Mouse Cere-
bellum
(A) RT-PCR for col18a1 and gapdhmRNAs fromRNA isolated fromP56mouse
hippocampus (H), cerebral cortex (CT), cerebellum (CB), olfactory bulb (OB),
and brain stem (BS).
(B) qPCR show col18a1 mRNA expression is developmentally regulated.
Expression levels normalized to gapdh. Data shown are means ± SD; n > 3 per
age. *Differs from P0 at p < 0.003 by one-way analysis of variance (ANOVA).
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those collagen IV-derived matricryptins that organize NMJ
formation (Ricard-Blum and Ballut, 2011). In addition to these
similarities with synaptogenic matricryptins, endostatin was
a good candidate to direct synaptogenesis in the mammalian
brain since it regulates neuromuscular circuit formation in
worms, flies, and fish (Ackley et al., 2003, Meyer and Moussian,
2009; Schneider and Granato, 2006). We therefore asked
whether endostatin contributes to cerebellar circuit formation.
To answer this question, we began by assessing whether en-
dostatin protein was present in cerebellum. Western blots (WBs)
with an antibody that specifically react with the endostatin
domain of collagen XVIII revealed two endostatin-containing
peptides (20 and 25 kDa) were present in cerebellum (Fig-
ure 1E). These fragments were absent from other brain regions
and from cerebellum of mice lacking collagen XVIII (col18a1/)
(Figures 1E and 1F). Similar to mRNA levels, increases in endo-
statin levels coincided with synaptogenesis (Figure 1G). Unfortu-
nately anti-endostatin antibodies worked poorly for localizing
this matricryptin in brain tissue. To circumvent this problem,
we probed for endostatin in cerebellar synaptosomes—
biochemical fractions enriched for synaptic elements. A single
20 kDa endostatin-containing fragment appeared present in
cerebellar synapses (Figures 1H and S1D), suggesting that
cleavage of endostatin from collagen XVIII may be different in
synaptic and extrasynaptic compartments of the cerebellum.
Together, these results demonstrate not only that Purkinje cells
generate collagen XVIII/endostatin during synapse formation
but also that endostatin is present at cerebellar synapses.
Collagen XVIII/Endostatin Is Necessary for CF Terminal
Formation
Based on the role of matricryptins at the NMJ, we hypothesized
that endostatin may be necessary to organize nerve terminal
assembly on to Purkinje cell dendrites. Nerve terminals from
four types of neurons synapse on to Purkinje cells: Parallel fibers
(PFs), which originate from granule cells, form excitatory termi-
nals on to dendritic spines of Purkinje cell dendrites; basket cells
(BCs) form inhibitory terminals on to the Purkinje cell soma and
axon initial segment; stellate cells (SCs) form inhibitory terminals
on to Purkinje cell dendrites; and CFs originate from inferior oli-
vary neurons and form excitatory terminals on the proximal shaft
of Purkinje cell dendrites (Figure 2A) (Sotelo, 2008). Since there is
nomethod to eliminate matricryptins without affecting full-length
collagen (because of the necessity of C-terminal matricryptins
for collagen trimerization within the endoplasmic reticulum), we
assessed synapses in col18a1/ mutants, which lack both(C and D) In situ hybridization show col18a1 expression is restricted to calb-
expressing Purkinje cells. Scale bar in (C), 15 mm; in (D), 150 mm.
(E) WBs demonstrate endostatin (endo)-containing fragments of collagen XVIII
in P56 cerebellar protein extracts.
(F) WBs of wild-type (WT) and col18a1/ mutant (KO) CB extracts demon-
strate antibody specificity.
(G) WBs show levels of endostatin-containing peptides are developmentally
regulated. Actin is a loading control for (E–G).
(H) WBs demonstrate a 20 kDa endostatin-containing fragment is present in
cerebellar synaptosome fractions (CBsy). CBsy lack nonsynaptic proteins,
such as GFAP, and are enriched for synaptic proteins (e.g., PSD95, Syt2).
collagen XVIII and endostatin. These mutants are viable and
have morphologically normal cerebella (Figure S2).
To visualize different subsets of nerve terminals on Purkinje
cell dendrites, we immunostained cerebellar tissue with anti-
bodies directed against distinct isoforms of nerve-terminal-
associated proteins (Figure 2B). PF terminals were labeled with
antibodies against vesicular glutamate transporter 1 (VGluT1)
or Bassoon (Fremeau et al., 2001; Richter et al., 1999). To label
inhibitory terminals, we used antibodies against synaptotagmin
2 (Syt2), a synaptic vesicle-associated protein expressed by
interneurons within the cerebellar molecular layer (and in a popu-
lation of PF terminals) (Figures 2B, S3, and S4) (Fox and Sanes,
2007). We detected no remarkable difference in the density or
distribution of VGluT1, Bassoon, or Syt2 in col18a1/ mutants
or littermate controls (Figures 2C–2K). Last, to label CF termi-
nals, we used antibodies against VGluT2 (Fremeau et al., 2001)
(Figures 2B and S4). We observed a dramatic and statistically
significant decrease in the number of VGluT2-containing vari-
cosities in the molecular layer of mutant cerebella (Figures
2L–2N). Not only were fewer VGluT2-rich varicosities observed,
but also VGluT2 appeared diffusely distributed throughout
mutant CFs rather than being aggregated into distinct varicosi-
ties (Figures 2L and 2M). The abnormal distribution of VGluT2,
together with little change in its expression pattern (Figures 2O
and 2P), suggested that collagen XVIII/endostatin is critical for
the clustering of presynaptic elements into nerve terminals,
a hallmark feature of presynaptic differentiation. Based on these
defects in synaptic organization, we asked whether col18a1/
mutants exhibit motor dysfunction in a standard accelerating
rotarod test (Shiotsuki et al., 2010). Col18a1/ mutants
performed significantly worse than controls in this assay (Fig-
ure 2Q), a phenotype that suggests (but does not prove) cere-
bellar defects.
Based upon the organizing role of collagen-derived matri-
cryptins at the NMJ, we hypothesized that reduced numbers
of VGluT2-containing CF terminals and motor deficits in
col18a1/ mutants arose as a result of endostatin’s role in
inducing presynaptic differentiation. However, CFs initially
arborize around the Purkinje cell somas and then subsequently
‘‘climb’’ the proximal shaft of Purkinje cell dendrites (Mason
and Gregory, 1984). Therefore, an alternative possibility was
that synaptic defects in col18a1/ mutants arose indirectly
due to defects in Purkinje cell dendritogenesis or the ability of
CFs to ascend these dendrites. To explore these possibilities,
we performed morphological characterizations of Purkinje cell
dendrites and CF arbors. Purkinje cell dendrites were labeled
by Golgi impregnation, a method in which a small percentage
of cerebellar cells were labeled stochastically (Figures S2E and
S2F). Areas occupied by individual Purkinje cell dendrites and
branch densities of these dendrites appeared indistinguishable
in mutant and control cerebella (Figures S2G and S2H).
To address whether CFs properly contacted and ascended
Purkinje cell dendrites in col18a1/ mutants, we explored
whether CF terminals formed on Purkinje cells in mutants.
Colabeling with antibodies against calbindin and VGluT2 re-
vealed that, although fewer VGluT2-containing CF terminals
were present in mutant cerebellum, terminals that were present
had correctly targeted Purkinje cell dendrites (Figures 2Rand 2S). To assess whether CFs ascended Purkinje cell
dendrites in mutants, we examined whether CF terminals ex-
tended as far into the molecular layer as in controls. VGluT2-
containing nerve terminals extended up through 75% of the
molecular layer in controls (Figure 2T). Although fewer VGluT2-
containing varicosities were observed in mutants, those varicos-
ities present appeared through an equivalent percentage of the
molecular layer (Figure 2T). These two findings suggest that CFs
were capable of targeting and ‘‘climbing’’ Purkinje cell dendrites
in the absence of collagen XVIII/endostatin. However, to assess
their morphology definitively, we anterogradely labeled CFs with
lipophilic cyanine dye (DiI) in P20 mutants and controls (Fig-
ures 2U and 2V). The average length of CF arbors and the
proportion of molecular layer that they crossed were unaltered
in col18a1/ mutants (Figures 2W and 2X). Taken together,
these studies reveal that reduced numbers of VGluT2-immuno-
reactive terminals did not result from altered Purkinje cell or CF
morphology.
Endostatin Induces CF Terminal Formation In Vitro
To address whether Purkinje cell-derived endostatin was
capable of inducing CF nerve terminal formation, we generated
dissociated cultures from the inferior olivary nucleus. Since cells
in this nucleus do not express col18a1, these cultures lack
endogenous endostatin (Figure S5). We therefore assessed
whether the application of recombinant endostatin onto these
neurons affected their CFs in vitro. Application of endostatin
had no appreciable affect on the number or morphology of
CF-generating inferior olivary neurons (data not shown), which
were identified by their expression of calbindin (Calb) (Figure 3A).
As we were interested in the axons (and not dendrites) of these
neurons, we labeled axons with antibodies against neurofila-
ment (NF), which predominantly labeled CF axons and not other
cells in our cultures based on their coexpression of Calb
(89.6% ± 2.1% [SD] of NF-expressing neurons’ coexpressed
Calb; N = 4 experiments; n = 416 neurons) (Figure 3B). Applica-
tion of endostatin on to these cultures produced a robust
increase in the clustering of VGluT2-immunoreactive terminals
on NF-positive CFs (Figures 3C–3E and 3H). It is important to
note that the presence of endostatin in vitro had no significant
affect on mRNA expression levels of vglut2 (Figure 3I), indicating
that endostatin was not merely altering VGluT2 production.
Moreover, endostatin-induced varicosities not only contained
VGluT2 but also contained other synaptic vesicle-associated
proteins such as SV2 and synaptophysin (Syn) (Figures 3F
and 3G), suggesting they were indeed sites of neurotransmitter
release (and not just sites of VGluT2 accumulation). Taken
together, these results demonstrate not only that collagen
XVIII/endostatin is necessary for CF terminal formation in vivo,
but also that endostatin is sufficient to induce presynaptic differ-
entiation of these terminals in vitro.
To test whether the ability of endostatin to induce presynaptic
differentiation was specific to CF axons, we repeated these
experiments with dissociated granule cells. We failed to detect
differences in the number of VGluT1-immunoreactive varicosi-
ties in the presence of recombinant endostatin (data not shown),
suggesting that the ability of endostatin to induce presynaptic
differentiation is cell type specific.Cell Reports 2, 223–230, August 30, 2012 ª2012 The Authors 225
Figure 2. Collagen XVIII/Endostatin Is Necessary for the Organization of CF Terminals
(A) Neurons that synapse onto Purkinje cells (PC). GC, granule cell; IO, inferior olivary neuron; PF, parallel fiber; BC, basket cell; SC, stellate cell; CF, climbing fiber.
(B) Nerve terminal markers used to label terminals on PCs. Parentheses indicate Syt2 is present in a small set of PF terminals.
(C–M) Immunostaining for VGluT1 (C and D), Bassoon (F andG), Syt2 (I and J), and VGluT2 (L andM) in P56 control (Ctl) and col18a1/mutant cerebellum. Insets
in (I and J) show high magnification of Syt2-positive axosomatic terminals on PCs (see arrows). Insets in (L and M) show high magnification of VGluT2 distribution
in CFs: note its diffuse axonal distribution in col18a1/mutants; see arrows in (L and M). In (E), (H), and (K), average fluorescent intensity of VGluT1-, Bassoon-,
and Syt2-immunoreactivity, respectively, in P56 control (Ctl) andmutants (KO). Data shown are means ±SEM; n > 4mice per genotype. Scale bar in (C), 30 mm; in
insets, 18 mm.
(N) Quantification of the total number of VGluT2-positive varicosities per image field in P14 and P56 col18a1/mutants compared to controls (dashed line). Data
shown are mean ± SD; n > 4 mice per genotype. *Differ from litter mate controls at p < 0.001 by Student’s t test.
(O) WBs show no difference in VGluT2 levels in P56 Ctl and KO cerebellum (CB). Actin was a loading control.
(P) qPCR of vglut2 mRNA expression levels in P56 IO and CB of KOs and controls (dashed line). Data are mean ± SEM; n = 3.
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Figure 3. Endostatin Induces CF Terminal
Formation In Vitro
(A) Inferior olivary neuron labeled by Calb-IHC
in vitro. Arrows indicate CF axon. Scale bar,
25 mm.
(B and B0) CF axons were labeled in vitro with
Calb- (B) and NF-IHC (B0). Scale bar in (B), 8 mm.
(C–E00) Control or BSA-treated CF axons had
few VGluT2-immunoreactive synaptic varicosities;
however, treatment with 0.1 mg/ml endostatin
(endo) induced varicosity formation. Neuronswere
double labeled for NF (C–E) and VGluT2 (C0–E0).
(C00–E00) represent the overlays of NF (green) and
VGluT2 (red) labeling.
(F–G00) Endostatin-induced VGluT2-positive vari-
cosities also contained other nerve-terminal-
associated-proteins, such as synaptophysin (Syn
in F) and SV2 (G). (F0 and G0) represent VGluT2
labeling and (F00 and G00) represent the merged
overlays of VGluT2 (red) and either Syn or SV2
(green). Scale bar in (G00), 25 mm for (C–G00).
(H) Quantification of the number of VGluT2-
positive synaptic varicosities in control and treated
cultures. Data shown are means ± SD: n > 4 ex-
periments in quadruplicate. *Differs from un-
treated or BSA-treated cultures at p < 0.0001
by Tukey-Kramer test for differences between
means.
(I) qPCR revealed that application of endo did
not significantly alter vglut2 mRNA expression.
Expression levels normalized to gapdh. Data
shown are means ± SD; n > 3.Endostatin Signals through a3b1 Integrins to Induce
Synaptic Differentiation
We next explored what receptors might transduce these endo-
statin-induced signals in inferior olivary neurons. Outside of the
nervous system, endostatin signals through avb3, avb5, and
a5b1 integrin heterodimers (Ricard-Blum and Ballut, 2011)—all
of which are expressed in the inferior olive (IO) (Figure S5E).
More important, immunostaining for the b1 and b3 integrin
subunits revealed that both were present on CF axons in vitro
(Figures 4A and 4B; 99% ± 1% of NF-immunoreactive [NF-IR]
axons contained b1 integrin, N = 3 experiments, n = 257 axons;
93% ± 3% of NF-IR axons contained b3 integrin, N = 3, n =
348). As the functions of b1- and b3-containing integrins are(Q) Adult KOs exhibit impaired mobility on a rotating rod. Data are mean ± SEM; n = 10 Ctls and 13 KOs. *
differences between means.
(R and S) Immunostaining for Calb and VGluT2 in P21 Ctl and KO cerebella. Scale bar, 25 mm.
(T) Quantification of the percent of ML crossed by VGluT2-containing nerve terminals. Data are mean ± SEM
(U and V) DiI-labeled CFs in the ML of P20 control and col18a1/ mutant cerebellum. Scale bar, 30 mm.
(W and X) CF length in ML of KO and Ctl cerebella. In (X), quantification of the extent of ML crossed by the CF
n = 26 control CFs and 23 mutants CFs.
Cell Reports 2, 223–230RGD-binding dependent, we tested
whether endostatin-induced synapto-
genesis could be blocked by RGD-con-
taining peptides. Indeed, application of
these peptides inhibited the ability of
endostatin to induce CF terminal forma-
tion (Figures 4F–4H and 4K).To determine which specific integrin heterodimer transduced
endostatin-mediated signals, we explored the expression of
the av and a5 integrin subunits on CF axons. Neither was present
on many CF axons (Figures 4C and 4D; 1% ± 1% of NF-IR axons
contained av integrin, N = 3, n = 335; 6% ± 1% of NF-IR axons
contained a5 integrin, N = 3, n = 271). We therefore explored
other integrin a subunits that form heterodimers with b1 or b3
subunits. One interesting candidate was the a3 integrin subunit:
a3b1 integrin (the only integrin containing the a3 subunit) binds in
an RGD-dependent fashion (Akula et al., 2002), is present on
nerve terminals (Cohen et al., 2000), and links synaptic cleft
molecules to active zone components within the nerve terminal
(Carlson et al., 2010). Here we show that nearly all CF axonsDiffer from Ctls at p < 0.05 by Tukey HSD Test for
; n = 60 measures from 3 mice.
s in KO and Ctl cerebella. Data are means ± SEM;
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Figure 4. Endostatin Signals through a3b1 Integrins to Induce Nerve Terminal Formation In Vitro
(A–E00) IHC revealed that the b1, b3, and a3 integrin subunits were present on NF-positive CF axons in vitro. (A–E) depict NF immunolabeling; (A0–E0 ) depict integrin
subunit labeling; (A00–E00) depicts the merged overlay of NF (green) and integrin (red) labeling. Scale bar, in (E), 20 mm.
(F–J00) Endostatin’s ability to induce the formation of VGluT2-positive synaptic varicosities was inhibited by the application of 10mMRGD peptides (G) or 25 mg/ml
function blocking anti-a3 integrin antibodies (I), but not by control peptides (RAD in H) or antibodies (IgG in J). (F–J) depict NF immunolabeling; (F0–J0) depict
VGluT2 labeling; (F00–J00) depicts the merged overlay of NF (green) and VGluT2 (red) labeling. Scale bar in (J), 25 mm.
(K) Quantification of the number of VGluT2-positive synaptic varicosities in cultures treated with combinations of endo, BSA, RAD peptides, RGD peptides,
control IgG antibodies, and function blocking anti-a3 integrin antibodies. Data shown are means ± SD: n>4 experiments in quadruplicate. *Cultures treated with
endo and either control peptides or antibodies differ from all other treatment groups at p < 0.0001 by Tukey-Kramer test for differences between means.
(L–M0) IHC revealed b1, but not a3, integrin subunits were present on cultured granule cell (GC) axons. (L andM) depict integrin immunolabeling; (L0 andM0) depict
the merged overlay of NF (green) and integrin (red) labeling. Scale bar in (M), 15 mm.
(N) WBs demonstrate the presence of the a3 and b1 integrin subunits in cerebellar extracts (CB) and cerebellar synaptosome fractions (CBsy).
(O) Antibodies directed against endostatin immunoprecipitated the a3 and b1 integrin subunits from both CB and CBsy.contained a3 integrin (Figure 4E; 99% ± 1% of NF-IR axons con-
tained a3 integrin, N = 3, n = 335). The distribution of this integrin
appeared evenly distributed throughout CF axons in control and
endostatin-treated cultures (Figure 4E; data not shown). In addi-
tion to in vitro experiments, WBs revealed that a3b1 integrins
were enriched in cerebellar synaptosome fractions (Figures 4N
and S1D). To test whether endostatin signaled through a3b1 in-
tegrins in our assays, inferior olivary neurons were treated with
function-blocking a3 integrin antibodies in conjunction with re-
combinant endostatin. Endostatin’s ability to induce nerve
terminal formation was abolished in the presence of these anti-
bodies (Figures 4I–4K). In contrast to CF axons, few axons
from dissociated granule cells contained a3 integrins (although
they did contain b1 integrins) (Figures 4L and 4M; 5.2% ± 1%
of NF-IR granule cell axons contained a3 integrin, N = 6,228 Cell Reports 2, 223–230, August 30, 2012 ª2012 The Authorsn = 256; 97.5% ± 0.9% of NF-IR axons contained b1 integrin,
N = 6, n = 184). We suspect that differences in the expression
of a3b1 integrins account for the cell-type-specific function of
endostatin.
Finally, since a3b1–endostatin interactions had not been
reported previously, we confirmed their interaction by immuno-
precipitating these integrin subunits from cerebellar and synap-
tosome extracts with endostatin antibodies (Figure 4O). Surface
plasmon resonance (SPR) binding assays were used to further
demonstrate that a3b1 integrin directly binds endostatin with
high affinity (KD = 9.0 ± 3.6 nM, n = 2). The interaction data
were best fit by a two-state interaction model (data not shown),
similar to the binding of endostatin to a5b1 and avb3 integrins
that we previously reported (Faye et al., 2009). Thus, a3b1 integ-
rin is a receptor for endostatin.
Themammalian cerebellum has become a well-studied model
for identifying synapse-specific signals that regulate neural
circuit formation (Umemori et al., 2004; Scheiffele et al., 2000;
Matsuda et al., 2010; Ango et al., 2004; Kalinovsky et al.,
2011). In this study, we have added to our understanding of cere-
bellar circuit formation by identifying a matricryptin-releasing
collagen that is necessary for the organization of CF terminals.
While previous roles for collagen XVIII/endostatin have been
described at the NMJ in worms, fish, and flies, we found that,
despite its importance in cerebellum, collagen XVIII is dispens-
able for NMJ formation in mice (Figure S6). In addition to report-
ing a matricryptin that regulates neural circuit formation in the
mammalian brain, our studies also provide a cellular mechanism
that may help explain why collagen XVIII deficiency in Knobloch
syndrome may predispose patients to neurological deficits
(Suzuki et al., 2002).
EXPERIMENTAL PROCEDURES
Animals
Wild-type mice were obtained from Charles River Laboratories (Wilmington,
MA, USA). Collagen XVIII null mice (col18a1/) were described previously
(Fukai et al., 2002). Standard rotarod experiments were performed on a
Rotamex-5 (Columbus Instruments, Columbus, OH, USA) (Shiotsuki et al.,
2010) with a 3 cm rod. At the onset of experiments, rods rotated at 1 rpm; how-
ever, every 15 s, the speed increased 1 rpm. The Rotamex-5 recorded the time
at which each mouse fell. A total of 13 mutants and 10 littermate controls were
analyzed. All analyses conformed to National Institutes of Health (NIH) guide-
lines and were carried out under protocols approved by the Virginia Com-
monwealth University (VCU) Institutional Animal Care and Use Committee.
RT-PCR
RNA isolation, RT-PCR, and real-time quantitative PCR were all performed as
previously described (Su et al., 2010). Primer sequences can be found in the
Extended Experimental Procedures.
Immunohistochemistry
Fluorescent immunohistochemistry (IHC) was performed on 16 mm cryosec-
tioned paraformaldehyde (PFA)-fixed brain tissue or cultured neurons as
described previously (Fox et al., 2007; Su et al., 2010). Images were acquired
on a Zeiss AxioImager A1 fluorescent microscope or a Leica SP2 confocal
microscope. When comparing different ages of tissues or between genotypes,
weacquired imageswith identical parameters. Tissues fromat least four animals
were analyzed for each genotype, and IHC analysis was performed on at least
eight random fields (875 mm 3 650 mm) per animal. Total number of puncta
per field was countedmanually. Average fluorescent intensities weremeasured
in ImageJ as previously described (Su et al., 2010). A list of the antibodies and
additional details can be found in the Extended Experimental Procedures.
In Situ Hybridization
Riboprobe generation and in situ hybridization (ISH) were performed as
described previously (Su et al., 2010). Sense and antisense riboprobes against
col18a1 were generated from a 967-base-pair fragment of col18a1, corre-
sponding to nucleotides (nt) 3190–4156, and were hydrolyzed to 500 nt.
WB and Immunoprecipitation Analysis
WBs and immunoprecipitation analyses (IPs) were performed as described
previously (Fox and Sanes, 2007; Su et al., 2010). A previously described rabbit
polyclonal antibody against endostatin was used for IPs (Faye et al., 2010).
Additional information can be found in the Extended Experimental Procedures.
In Vitro Cultures
IOs were dissected from P0mouse brains and were digested in 0.25% trypsin.
Trypsin was inactivated, and tissue was transferred to Neurobasal mediumcontaining 0.5 mM L-glutamine, 25 mM L-glutamate, 10 mg/ml gentamicin,
and 10% fetal bovine serum (FBS). Single-cell suspensions were plated on
poly-L-lysine-treated chamber slides and were cultured for 4 days. After 2
additional days in Neurobasal medium containing 0.5 mM L-glutamine,
10 mg/ml gentamicin, and B27 supplement, IO cells were treated with endosta-
tin (0.1 mg/ml; ProSpec Inc.), bovine serum albumin (BSA) (0.1 mg/ml), RGD
(10 mM), RAD (10 mM), integrin a3 antibody (25 mg/ml; Millipore), and/or mouse
immunoglobulin G (IgG) (25 mg/ml). After 2 days, cells were fixed with 4% PFA
and immunostained. Granule cell cultures were generated as previously
described (Umemori et al., 2004) and were treated as described earlier.
CF Labeling
CF labeling was performed using the method of Kiyohara et al. (2003). Brains
were fixed in 4% PFA and DiI (0.5%–1.0% in dimethyl sulfoxide; DMSO) was
injected into the inferior cerebellar peduncle. Brains were incubated in 4%
PFA at 37C for 3 weeks, sectioned with a vibratome, and imaged with a Leica
SP2 scanning confocal microscope. CF arbors and the extent of the molecular
layer were measured in ImageJ.
SPR Binding Assays
The SPR binding assays were performed in a Biacore T200 instrument (GE
Healthcare). Recombinant human endostatin was covalently immobilized to
the dextran matrix of a CM5 sensor chip via its primary amine groups as
described previously (Faye et al., 2009). Sensorgrams collected on the control
flow cell were automatically subtracted from the sensorgrams obtained on im-
mobilized endostatin to yield specific binding responses. Kinetic and affinity
constants were calculated by injecting several concentrations of a3b1 integrin
(Millipore). Complexes were dissociated with 2 M NaCl. Rate constants were
calculated using Biacore T200 software.
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